A digital view of the world illustrates how Astellas is a global company committed to serving patients worldwide.

News

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.

Month Year

Month Year

Oct 17, 2014

Astellas and CoMentis to End Agreement to Collaborate on Research, Development and Commercialization of Beta-Secretase Inhibitors for Alzheimer's Disease

Tokyo, Japan & South San Francisco CA, October 16, 2014 –Astellas Pharma Inc. (TSE: 4503) and CoMentis, Inc. today announced the companies will end their worldwide exclusive collaboration...

Read more about Astellas and CoMentis to End Agreement to Collaborate on Research, Development and Commercialization of Beta-Secretase Inhibitors for Alzheimer's Disease
Oct 15, 2014

Astellas donates six wheelchair vans through the Flying Star Fund, an employee-led social contribution fund

Read more about Astellas donates six wheelchair vans through the Flying Star Fund, an employee-led social contribution fund
Oct 14, 2014

ASTELLAS ANNOUNCES RESEARCH COLLABORATION WITH HARVARD MEDICAL SCHOOL INVESTIGATOR FOR TREATMENT OF RETINAL DEGENERATION - AIMing to establish a new treatment for ophthalmologic diseases -

Tokyo, October 14th, 2014 --- Astellas Pharma Inc. (Tokyo: 4503, President & CEO: Yoshihiko Hatanaka, “Astellas”) announced today a research collaboration with an investigator at Harvard...

Read more about ASTELLAS ANNOUNCES RESEARCH COLLABORATION WITH HARVARD MEDICAL SCHOOL INVESTIGATOR FOR TREATMENT OF RETINAL DEGENERATION - AIMing to establish a new treatment for ophthalmologic diseases -
Oct 9, 2014

Astellas promotes employment of people with disabilities by placing the Green Supply Support Office in Yaizu City, Shizuoka Prefecture

Read more about Astellas promotes employment of people with disabilities by placing the Green Supply Support Office in Yaizu City, Shizuoka Prefecture
Sep 16, 2014

Astellas has been Selected for the Fourth Consecutive Year for the Dow Jones Sustainability Asia Pacific Index

Tokyo, September 16, 2014 - Astellas Pharma Inc. (TSE: 4503; Headquarters: Tokyo; President & CEO: Yoshihiko Hatanaka) announced that it has been selected for the fourth consecutive year for the...

Read more about Astellas has been Selected for the Fourth Consecutive Year for the Dow Jones Sustainability Asia Pacific Index

Show per page

Discover more

Return to media homepage

Follow us

Subscribe to news alerts